Exact Mass: 509.15802620000005
Exact Mass Matches: 509.15802620000005
Found 336 metabolites which its exact mass value is equals to given mass value 509.15802620000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
NK 250
C26H27N3O4S2 (509.14429020000006)
Fluphenazine hydrochloride
C22H28Cl2F3N3OS (509.12821340000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
4-cis-Hydroxycyclohexyl glyburide
C23H28ClN3O6S (509.1387258000001)
4-cis-Hydroxycyclohexyl glyburide is a metabolite of glyburide. Glibenclamide, also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis). (Wikipedia)
Dide-O-methyl-4-O-alpha-D-glucopyranosylsimmondsin
Dide-O-methyl-4-O-alpha-D-glucopyranosylsimmondsin is found in coffee and coffee products. Dide-O-methyl-4-O-alpha-D-glucopyranosylsimmondsin is a constituent of jojoba meal (Simmonsia chinensis). Constituent of jojoba meal (Simmonsia chinensis). Di-demethylsimmondsin 4-alpha-D-glucoside is found in coffee and coffee products, fats and oils, and nuts.
2-trans-Hydroxycyclohexyl glyburide
C23H28ClN3O6S (509.1387258000001)
2-trans-Hydroxycyclohexyl glyburide is a metabolite of glyburide. Glibenclamide, also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis). (Wikipedia)
4-trans-Hydroxycyclohexyl glyburide
C23H28ClN3O6S (509.1387258000001)
4-trans-Hydroxycyclohexyl glyburide is a metabolite of glyburide. Glibenclamide, also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis). (Wikipedia)
3-trans-Hydroxycyclohexyl glyburide
C23H28ClN3O6S (509.1387258000001)
3-trans-Hydroxycyclohexyl glyburide is a metabolite of glyburide. Glibenclamide, also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis). (Wikipedia)
3-cis-Hydroxycyclohexyl glyburide
C23H28ClN3O6S (509.1387258000001)
3-cis-Hydroxycyclohexyl glyburide is a metabolite of glyburide. Glibenclamide, also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. (Wikipedia)
3-Hydroxyglibenclamide
C23H28ClN3O6S (509.1387258000001)
4-[[2-[[(5Z)-5-(2,6-Dioxo-1,3-dipropylpurin-8-ylidene)-1-methyl-2H-pyrazol-3-yl]oxy]acetyl]amino]benzoic acid
C24H27N7O6 (509.20227220000004)
rac trans-4-Hydroxy Glyburide
C23H28ClN3O6S (509.1387258000001)
3-OxoUndecanoyl-CoA
3-oxoundecanoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is a 3-oxoundecanoic acid thioester of coenzyme A. 3-oxoundecanoyl-coa is an acyl-CoA with 11 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. 3-oxoundecanoyl-coa is therefore classified as a medium chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. 3-oxoundecanoyl-coa, being a medium chain acyl-CoA is a substrate for medium chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, 3-OxoUndecanoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of 3-OxoUndecanoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts 3-OxoUndecanoyl-CoA into 3-OxoUndecanoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, 3-OxoUndecanoylcarnitine is converted back to 3-OxoUndecanoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of 3-OxoUndecanoyl-CoA occurs in four steps. First, since 3-OxoUndecanoyl-CoA is a medium chain acyl-CoA it is the substrate for a medium chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of 3-OxoUndecanoyl-CoA, creating a double bond between the alpha and beta carbons. FAD is the hydrogen acceptor, yielding FADH2. Second, Enoyl-CoA hydrase catalyzes the addition of water across the newly formed double bond to make an alcohol. Third, 3-hydroxyacyl-CoA dehydrogenase oxidizes the alcohol group to a ketone and NADH is produc...
4,5-didemethyl-4-O-alpha-D-glucopyranosylsimmondsin
Evista
C28H28ClNO4S (509.1427478000001)
Raloxifene hydrochloride is a hydrochloride salt resulting from the reaction of equimolar amounts of raloxifene and hydrogen chloride. It has a role as a bone density conservation agent, an estrogen antagonist and an estrogen receptor modulator. It contains a raloxifene(1+). Raloxifene Hydrochloride is the hydrochloride salt form of raloxifene, a selective benzothiophene estrogen receptor modulator (SERM) with lipid lowering effects and activity against osteoporosis. Raloxifene hydrochloride specifically binds to estrogen receptors in responsive tissue, including liver, bone, breast, and endometrium. The resulting ligand-receptor complex is translocated to the nucleus where, depending on the tissue type, it promotes or suppresses the transcription of estrogen-regulated genes, thereby exerting its agonistic or antagonistic effects. This agent functions as an estrogen agonist in lipid metabolism, thereby decreasing total and LDL cholesterol levels. In tissue like bone, it decreases bone resorption and bone turnover and increases bone mineral density. Raloxifene hydrochloride acts as an estrogen antagonist in uterine and breast tissue. This agent also exerts an anti-proliferative effect on estrogen-sensitive breast cancer. A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue. See also: Raloxifene (has active moiety). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D050071 - Bone Density Conservation Agents C1892 - Chemopreventive Agent Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation?selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue[1].
Raloxifene Hcl
C28H28ClNO4S (509.1427478000001)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D050071 - Bone Density Conservation Agents C1892 - Chemopreventive Agent Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation?selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue[1].
Ala Cys Met Trp
Ala Cys Trp Met
Ala Met Cys Trp
Ala Met Trp Cys
Ala Trp Cys Met
Ala Trp Met Cys
Cys Ala Met Trp
Cys Ala Trp Met
Cys Cys Glu Arg
Cys Cys Arg Glu
Cys Cys Val Trp
Cys Cys Trp Val
Cys Asp Ser Trp
C21H27N5O8S (509.15802620000005)
Cys Asp Trp Ser
C21H27N5O8S (509.15802620000005)
Cys Glu Cys Arg
Cys Glu Lys Met
Cys Glu Met Lys
Cys Glu Met Gln
Cys Glu Gln Met
Cys Glu Arg Cys
Cys His His Asn
Cys His Asn His
Cys Lys Glu Met
Cys Lys Met Glu
Cys Met Ala Trp
Cys Met Glu Lys
Cys Met Glu Gln
Cys Met Lys Glu
Cys Met Gln Glu
Cys Met Trp Ala
Cys Asn His His
Cys Pro Gln Tyr
C22H31N5O7S (509.19440960000003)
Cys Pro Tyr Gln
C22H31N5O7S (509.19440960000003)
Cys Gln Glu Met
Cys Gln Met Glu
Cys Gln Pro Tyr
C22H31N5O7S (509.19440960000003)
Cys Gln Tyr Pro
C22H31N5O7S (509.19440960000003)
Cys Arg Cys Glu
Cys Arg Glu Cys
Cys Ser Asp Trp
C21H27N5O8S (509.15802620000005)
Cys Ser Trp Asp
C21H27N5O8S (509.15802620000005)
Cys Thr Thr Trp
C22H31N5O7S (509.19440960000003)
Cys Thr Trp Thr
C22H31N5O7S (509.19440960000003)
Cys Val Cys Trp
Cys Val Trp Cys
Cys Trp Ala Met
Cys Trp Cys Val
Cys Trp Asp Ser
C21H27N5O8S (509.15802620000005)
Cys Trp Met Ala
Cys Trp Ser Asp
C21H27N5O8S (509.15802620000005)
Cys Trp Thr Thr
C22H31N5O7S (509.19440960000003)
Cys Trp Val Cys
Cys Tyr Pro Gln
C22H31N5O7S (509.19440960000003)
Cys Tyr Gln Pro
C22H31N5O7S (509.19440960000003)
Asp Cys Ser Trp
C21H27N5O8S (509.15802620000005)
Asp Cys Trp Ser
C21H27N5O8S (509.15802620000005)
Asp Asp Phe Asn
C21H27N5O10 (509.17578420000007)
Asp Asp Asn Phe
C21H27N5O10 (509.17578420000007)
Asp Phe Asp Asn
C21H27N5O10 (509.17578420000007)
Asp Phe Asn Asp
C21H27N5O10 (509.17578420000007)
Asp Met Met Asn
Asp Met Asn Met
Asp Asn Asp Phe
C21H27N5O10 (509.17578420000007)
Asp Asn Phe Asp
C21H27N5O10 (509.17578420000007)
Asp Asn Met Met
Asp Ser Cys Trp
C21H27N5O8S (509.15802620000005)
Asp Ser Trp Cys
C21H27N5O8S (509.15802620000005)
Asp Trp Cys Ser
C21H27N5O8S (509.15802620000005)
Asp Trp Ser Cys
C21H27N5O8S (509.15802620000005)
Glu Cys Cys Arg
Glu Cys Lys Met
Glu Cys Met Lys
Glu Cys Met Gln
Glu Cys Gln Met
Glu Cys Arg Cys
Glu Lys Cys Met
Glu Lys Met Cys
Glu Met Cys Lys
Glu Met Cys Gln
Glu Met Lys Cys
Glu Met Gln Cys
Glu Gln Cys Met
Glu Gln Met Cys
Glu Arg Cys Cys
Phe Asp Asp Asn
C21H27N5O10 (509.17578420000007)
Phe Asp Asn Asp
C21H27N5O10 (509.17578420000007)
Phe Asn Asp Asp
C21H27N5O10 (509.17578420000007)
His Cys His Asn
His Cys Asn His
His His Cys Asn
His His Asn Cys
His Asn Cys His
His Asn His Cys
Lys Cys Glu Met
Lys Cys Met Glu
Lys Glu Cys Met
Lys Glu Met Cys
Lys Met Cys Glu
Lys Met Glu Cys
Met Ala Cys Trp
Met Ala Trp Cys
Met Cys Ala Trp
Met Cys Glu Lys
Met Cys Glu Gln
Met Cys Lys Glu
Met Cys Gln Glu
Met Cys Trp Ala
Met Asp Met Asn
Met Asp Asn Met
Met Glu Cys Lys
Met Glu Cys Gln
Met Glu Lys Cys
Met Glu Gln Cys
Met Lys Cys Glu
Met Lys Glu Cys
Met Met Asp Asn
Met Met Asn Asp
Met Met Gln Thr
Met Met Thr Gln
Met Asn Asp Met
Met Asn Met Asp
Met Gln Cys Glu
Met Gln Glu Cys
Met Gln Met Thr
Met Gln Thr Met
Met Ser Ser Trp
C22H31N5O7S (509.19440960000003)
Met Ser Trp Ser
C22H31N5O7S (509.19440960000003)
Met Thr Met Gln
Met Thr Gln Met
Met Trp Ala Cys
Met Trp Cys Ala
Met Trp Ser Ser
C22H31N5O7S (509.19440960000003)
Asn Cys His His
Asn Asp Asp Phe
C21H27N5O10 (509.17578420000007)
Asn Asp Phe Asp
C21H27N5O10 (509.17578420000007)
Asn Asp Met Met
Asn Phe Asp Asp
C21H27N5O10 (509.17578420000007)
Asn His Cys His
Asn His His Cys
Asn Met Asp Met
Asn Met Met Asp
Pro Cys Gln Tyr
C22H31N5O7S (509.19440960000003)
Pro Cys Tyr Gln
C22H31N5O7S (509.19440960000003)
Pro Gln Cys Tyr
C22H31N5O7S (509.19440960000003)
Pro Gln Tyr Cys
C22H31N5O7S (509.19440960000003)
Pro Tyr Cys Gln
C22H31N5O7S (509.19440960000003)
Pro Tyr Gln Cys
C22H31N5O7S (509.19440960000003)
Gln Cys Glu Met
Gln Cys Met Glu
Gln Cys Pro Tyr
C22H31N5O7S (509.19440960000003)
Gln Cys Tyr Pro
C22H31N5O7S (509.19440960000003)
Gln Glu Cys Met
Gln Glu Met Cys
Gln Met Cys Glu
Gln Met Glu Cys
Gln Met Met Thr
Gln Met Thr Met
Gln Pro Cys Tyr
C22H31N5O7S (509.19440960000003)
Gln Pro Tyr Cys
C22H31N5O7S (509.19440960000003)
Gln Thr Met Met
Gln Tyr Cys Pro
C22H31N5O7S (509.19440960000003)
Gln Tyr Pro Cys
C22H31N5O7S (509.19440960000003)
Arg Cys Cys Glu
Arg Cys Glu Cys
Arg Glu Cys Cys
Ser Cys Asp Trp
C21H27N5O8S (509.15802620000005)
Ser Cys Trp Asp
C21H27N5O8S (509.15802620000005)
Ser Asp Cys Trp
C21H27N5O8S (509.15802620000005)
Ser Asp Trp Cys
C21H27N5O8S (509.15802620000005)
Ser Met Ser Trp
C22H31N5O7S (509.19440960000003)
Ser Met Trp Ser
C22H31N5O7S (509.19440960000003)
Ser Ser Met Trp
C22H31N5O7S (509.19440960000003)
Ser Ser Trp Met
C22H31N5O7S (509.19440960000003)
Ser Trp Cys Asp
C21H27N5O8S (509.15802620000005)
Ser Trp Asp Cys
C21H27N5O8S (509.15802620000005)
Ser Trp Met Ser
C22H31N5O7S (509.19440960000003)
Ser Trp Ser Met
C22H31N5O7S (509.19440960000003)
Thr Cys Thr Trp
C22H31N5O7S (509.19440960000003)
Thr Cys Trp Thr
C22H31N5O7S (509.19440960000003)
Thr Met Met Gln
Thr Met Gln Met
Thr Gln Met Met
Thr Thr Cys Trp
C22H31N5O7S (509.19440960000003)
Thr Thr Trp Cys
C22H31N5O7S (509.19440960000003)
Thr Trp Cys Thr
C22H31N5O7S (509.19440960000003)
Thr Trp Thr Cys
C22H31N5O7S (509.19440960000003)
Val Cys Cys Trp
Val Cys Trp Cys
Val Trp Cys Cys
Trp Ala Cys Met
Trp Ala Met Cys
Trp Cys Ala Met
Trp Cys Cys Val
Trp Cys Asp Ser
C21H27N5O8S (509.15802620000005)
Trp Cys Met Ala
Trp Cys Ser Asp
C21H27N5O8S (509.15802620000005)
Trp Cys Thr Thr
C22H31N5O7S (509.19440960000003)
Trp Cys Val Cys
Trp Asp Cys Ser
C21H27N5O8S (509.15802620000005)
Trp Asp Ser Cys
C21H27N5O8S (509.15802620000005)
Trp Met Ala Cys
Trp Met Cys Ala
Trp Met Ser Ser
C22H31N5O7S (509.19440960000003)
Trp Ser Cys Asp
C21H27N5O8S (509.15802620000005)
Trp Ser Asp Cys
C21H27N5O8S (509.15802620000005)
Trp Ser Met Ser
C22H31N5O7S (509.19440960000003)
Trp Ser Ser Met
C22H31N5O7S (509.19440960000003)
Trp Thr Cys Thr
C22H31N5O7S (509.19440960000003)
Trp Thr Thr Cys
C22H31N5O7S (509.19440960000003)
Trp Val Cys Cys
Tyr Cys Pro Gln
C22H31N5O7S (509.19440960000003)
Tyr Cys Gln Pro
C22H31N5O7S (509.19440960000003)
Tyr Pro Cys Gln
C22H31N5O7S (509.19440960000003)
Tyr Pro Gln Cys
C22H31N5O7S (509.19440960000003)
Tyr Gln Cys Pro
C22H31N5O7S (509.19440960000003)
Tyr Gln Pro Cys
C22H31N5O7S (509.19440960000003)
Dide-O-methyl-4-O-a-D-glucopyranosylsimmondsin
[nitrilotri(methylene)]tris(phosphonic) acid, compound with 2-aminoethanol and 2,2,2-nitrilotriethanol
Hexadecanoic acid, (2S)-4-bromo-2-hydroxy-4-phosphonobutyl ester, sodium salt
C20H40BrNaO6P (509.1643430000001)
N-ACETYL-2-CHLORO-2-DEOXYNEURAMINIC ACID METHYL ESTER 4,7,8,9-TETRAACETATE
C20H28ClNO12 (509.1299958000001)
Rhodium(1+),dichlorotetrakis(pyridine)-, chloride (1:1), (OC-6-12)-
(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-7-(phenylmethoxy)-2H-pyrido[1,2:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
1H-Indole-1-carboxylic acid, 2-borono-5-[[4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]sulfonyl]-, 1-(1,1-dimethylethyl) ester (9CI)
5-bromo-4-chloro-3-indoxyl oleate
C26H37BrClNO2 (509.16960320000004)
TETRA-N-BUTYLAMMONIUM DICHLOROAURATE
C16H36AuCl2N (509.18902560000004)
2-[[[4-[bis(2-methoxyethyl)sulfamoyl]phenyl]-oxomethyl]amino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide
3-cis-Hydroxycyclohexyl glyburide
C23H28ClN3O6S (509.1387258000001)
3-cis-Hydroxycyclohexyl glyburide is a metabolite of glyburide. Glibenclamide, also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. (Wikipedia)
N-[4-[(4,6-dimethyl-2-pyrimidinyl)sulfamoyl]phenyl]-2-phenyl-4-quinolinecarboxamide
C28H23N5O3S (509.15215280000007)
[2-[(2-Methoxyphenyl)methylamino]-2-oxoethyl] 2-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]sulfanylpyridine-3-carboxylate
C26H27N3O6S (509.1620482000001)
N-[4-[(4-methyl-1-piperidinyl)sulfonyl]phenyl]-2-[(4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]acetamide
N-[(1R,3S,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C24H26F3N3O6 (509.17736120000006)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C24H26F3N3O6 (509.17736120000006)
N-[(1R,3R,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
N-[(1R,3S,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
4-chloro-N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
4-chloro-N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
4-chloro-N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C24H26F3N3O6 (509.17736120000006)
N-[(1S,3S,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
C27H31N3O5S (509.19843160000005)
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
C27H31N3O5S (509.19843160000005)
[(1S)-1-ethylsulfonyl-7-methoxy-2-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C21H27N5O6S2 (509.14026820000004)
[(1R)-1-ethylsulfonyl-7-methoxy-2-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C21H27N5O6S2 (509.14026820000004)
4,4,4-trifluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C21H30F3N3O6S (509.18073160000006)
4,4,4-trifluoro-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C21H30F3N3O6S (509.18073160000006)
4,4,4-trifluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C21H30F3N3O6S (509.18073160000006)
4-chloro-N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
4-chloro-N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
4-chloro-N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
4-chloro-N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
4-chloro-N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C24H32ClN3O5S (509.17510920000007)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C24H26F3N3O6 (509.17736120000006)
N-[(1R,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
C27H31N3O5S (509.19843160000005)
N-methyl-N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-L-alpha-aspartyl-L-lysyl-beta-alanine
5-chloro-N-[2-[4-[(2-hydroxycyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-2-methoxybenzamide
C23H28ClN3O6S (509.1387258000001)
Dide-O-methyl-4-O-alpha-D-glucopyranosylsimmondsin
NIK250
C26H27N3O4S2 (509.14429020000006)
CYM 9484
C27H31N3O3S2 (509.18067360000003)
CYM 9484 is a selective and highly potent neuropeptide Y (NPY) Y2 receptor antagonist with an IC50 value of 19 nM[1].
methyl (2r,8s)-4-hydroxy-2,8-dimethyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h-pyrrolo[3,2-e]indole-2-carboxylate
C26H27N3O8 (509.17980620000003)
9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatricyclo[19.3.1.0⁵,²⁴]pentacosa-1(24),2,4,10,16,19,21-heptaene-6,15,23,25-tetrone
2-[2,4-dihydroxy-3,6-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})cyclohexylidene]acetonitrile
(12s,13s,16e)-9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatricyclo[19.3.1.0⁵,²⁴]pentacosa-1(24),2,4,10,16,19,21-heptaene-6,15,23,25-tetrone
(2e)-3-(4-{[(1s,2s)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
(9s,10e,12r,17r,24r)-9-ethyl-4,24-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[15.6.1.0⁵,²³.0²⁰,²⁴]tetracosa-1(23),2,4,10,15,20-hexaene-6,14,18,22-tetrone
2-[(1z,2r,3r,4r,6s)-2,4-dihydroxy-3,6-bis({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})cyclohexylidene]acetonitrile
1-[3-(3-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]carbamoyl}-9h-pyrido[3,4-b]indol-1-yl)propanoyl]pyrrolidine-2-carboxylic acid
C25H27N5O7 (509.19103920000003)
2-{[4-(dimethylamino)-5-methoxy-6-methyloxan-2-yl]oxy}-2-ethyl-1,6,9-trihydroxybenzo[b]fluorene-5,10-dione
16,19-dihydroxy-10-(hydroxymethyl)-7,18-dimethoxy-6,17,21-trimethyl-5,8,14-trioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15,17,19-pentaene-12-carbonitrile
C26H27N3O8 (509.17980620000003)
(2r)-3-{[(1r,3r,4ar,10as)-3-(carboxymethyl)-9,10a-dihydroxy-5,10-dioxo-1-propyl-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid
C23H27NO10S (509.1355602000001)
n-{16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl}-n-methylcarbamimidic acid
C29H27N5O4 (509.20629420000006)
[(e)-[(5s,6r,7s,8s)-5,6,7,8-tetrahydroxy-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}decylidene]amino]oxysulfonic acid
(10e,12s,13s,16z)-9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatricyclo[19.3.1.0⁵,²⁴]pentacosa-1(24),2,4,10,16,19,21-heptaene-6,15,23,25-tetrone
3-(4-{[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
(9r,10e,12s,13s,16e)-9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatricyclo[19.3.1.0⁵,²⁴]pentacosa-1(24),2,4,10,16,19,21-heptaene-6,15,23,25-tetrone
(2s)-1-[3-(3-{[(1s)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]carbamoyl}-9h-pyrido[3,4-b]indol-1-yl)propanoyl]pyrrolidine-2-carboxylic acid
C25H27N5O7 (509.19103920000003)
12-[4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]-15-hydroxy-3,17-dimethoxy-5-methyl-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-8-one
12-[(2s,3r,4s,5s,6r)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]-15-hydroxy-3,17-dimethoxy-5-methyl-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-8-one
n-[(2s,3r,4r,6r)-16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl]-n-methylcarbamimidic acid
C29H27N5O4 (509.20629420000006)
26-hydroxy-14-methanesulfonyl-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
C27H31N3O5S (509.19843160000005)
(1r,2s,10r,12r,13r)-16,19-dihydroxy-10-(hydroxymethyl)-7,18-dimethoxy-6,17,21-trimethyl-5,8,14-trioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15,17,19-pentaene-12-carbonitrile
C26H27N3O8 (509.17980620000003)
12-[(2s,3r,4s,5r,6s)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]-15-hydroxy-3,17-dimethoxy-5-methyl-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-8-one
(10e,12s,13s,16e)-9-ethyl-4,12,19-trihydroxy-3,13,16-trimethyl-14-oxa-20-azatricyclo[19.3.1.0⁵,²⁴]pentacosa-1(24),2,4,10,16,19,21-heptaene-6,15,23,25-tetrone
2-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-methoxy-6-methyloxan-2-yl]oxy}-2-ethyl-1,6,9-trihydroxybenzo[b]fluorene-5,10-dione
(9s,10e,12r,15z,17r,24r)-9-ethyl-4,24-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[15.6.1.0⁵,²³.0²⁰,²⁴]tetracosa-1(23),2,4,10,15,20-hexaene-6,14,18,22-tetrone
9-ethyl-4,24-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[15.6.1.0⁵,²³.0²⁰,²⁴]tetracosa-1(23),2,4,10,15,20-hexaene-6,14,18,22-tetrone
3-{[3-(carboxymethyl)-9,10a-dihydroxy-5,10-dioxo-1-propyl-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid
C23H27NO10S (509.1355602000001)